In addition, the combination of SNHG1 knockdown and TERT inhibitor administration showed a synergistic inhibitory effect on breast cancer growth which may provide a potential therapy for clinical therapy for breast cancer in near future. Here, SNHG1 is linked to breast carcinoma.